Braskem S.A. BAK

NYS: BAK | ISIN: US1055321053   14/11/2024
5,190 USD (-1,52%)
(-1,52%)   14/11/2024

Braskem posts Recurring EBITDA of US$320 million in the quarter, 39% higher than 1Q24 and 128% higher than 2Q23

Gepubliceerd op 8 augustus 2024 om 17:00

SÃO PAULO, Aug. 8, 2024 /PRNewswire/ -- BRASKEM S.A. (B3: BRKM3, BRKM5 and BRKM6; NYSE: BAK; LATIBEX: XBRK) the largest resin producer in the Americas and the world's leading biopolymers producer, presents its 2Q24 Earnings Release.

2Q24 HIGHLIGHTS
CONSOLIDATED

  • Recurring EBITDA of US$320 million, around R$1,667million, higher than 1Q24 (+39%) and 2Q23 (+128%).
  • Cash position of US$2.8 billion, ensuring coverage of debt maturities over the next 5 years.
  • Operating Cash Generation¹ of US$69 million, around R$357 million, higher than 1Q24 (+US$170 MM) and 2Q23 (+US$82 MM).
  • Braskem Idesa Sales: Best Sales performance since 3Q17, with sales volume of 233 kton, higher than 1Q24 (+12%) and 2Q23 (+9%)

The full earnings release is available on the Company's IR website: www.braskem-ri.com.br/en

Braskem will host conference calls to discuss its Results Thursday, August 8 at 10:00 a.m. US ET.

Additional information may be obtained from the Investor Relations Department at +55 11 3576-9531 or braskem-ri@braskem.com.br.

1 Cash Flow Generation (=) Net Cash Generated from Operating Activities (-) Leniency Agreement (+) effects of
reclassifications between the lines of Financial Investments (includes LFT's and LF's) and Cash and Cash Equivalents (+)
Net Cash used in Investing Activities (+) Leasing.

 

Cision View original content:https://www.prnewswire.com/news-releases/braskem-posts-recurring-ebitda-of-us320-million-in-the-quarter-39-higher-than-1q24-and-128-higher-than-2q23-302218048.html

SOURCE Braskem

Mijn selecties